Medistim ASA

Oslo Stock Exchange MEDI.OL

Medistim ASA Capital Expenditure for the year ending December 31, 2023: USD -2.92 M

Medistim ASA Capital Expenditure is USD -2.92 M for the year ending December 31, 2023, a -35.65% change year over year. Capital expenditure is cash spent on acquiring or maintaining fixed assets, such as property, plants, and equipment (PP&E).

Medistim ASA Capital Expenditure for the year ending December 31, 2022 was USD -2.15 M, a -65.37% change year over year.
Medistim ASA Capital Expenditure for the year ending December 31, 2021 was USD -1.30 M, a -4.92% change year over year.
Medistim ASA Capital Expenditure for the year ending December 31, 2020 was USD -1.24 M, a 20.42% change year over year.
Medistim ASA Capital Expenditure for the year ending December 31, 2019 was USD -1.56 M, a 17.69% change year over year.

Key data

Date	Capital Expenditure	Free Cash Flow	Depreciation And Amortization	Deferred Income Tax

Oslo Stock Exchange: MEDI.OL

Medistim ASA

CEO	Ms. Kari Eian Krogstad
IPO Date	May 28, 2004
Location	Norway
Headquarters	Økernveien 94
Employees	150
Sector	Healthcare
Industries Medical Instruments 3D Printing

Description

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardio-vascular surgery in the United States, Europe, Asia, and internationally. It offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and transit TTFM in a single system for vascular surgery; and imaging probes for intraoperative use. The company also provides various flow probes, such as QuickFit TTFM probes to accurately measure blood volume flow intraoperatively in various range of surgical applications; Vascular TTFM probes for enhancing surgical outcomes; and doppler probes that are used on the surface of the heart/vessel to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, it distributes and sells third party medical equipment. The company was incorporated in 1984 and is headquartered in Oslo, Norway.

Key trends

Past 5 years